🇺🇸 Short selling in United States, Q3 2022

From 15 Jul 2022 to 30 Sep 2022, 4,899 United States companies carried disclosed short positions. The quarter's highest single reading was HERON THERAPEUTICS, INC. at 39.45% on 29 Jul 2022. 86 companies appeared in the data for the first time. 102 left it. Figures are disclosed positions from official FINRA data.

← Q2 2022 Q4 2022 →

Cite this page

Plain

Short position data for Short selling in United States, Q3 2022: FINRA, compiled by howshorted.com, settlement date 30 Sep 2022. https://howshorted.com/us/review/2022-q3/

Wikipedia

<ref>{{cite web |title=Short selling in United States, Q3 2022 short position data |url=https://howshorted.com/us/review/2022-q3/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2022-09-30 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-short-selling-in-united-states-q3-2022-2022-09-30,
  title        = {Short selling in United States, Q3 2022 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/review/2022-q3/}},
  note         = {Data: FINRA, settlement date 30 Sep 2022; accessed 2026-10-13},
  year         = {2022}
}

Biggest rises of the quarter

bluebird bio, Inc.+10.68pp to 29.45%
Dream Finders Homes, Inc.+10.67pp to 14.60%
CROSS COUNTRY HEALTHCARE INC+9.60pp to 9.61%
Cabaletta Bio, Inc.+9.33pp to 16.08%
Syros Pharmaceuticals, Inc.+9.02pp to 12.31%

Biggest falls of the quarter

INTERCEPT PHARMACEUTICALS, INC.−22.25pp to 12.45%
Eos Energy Enterprises, Inc.−16.48pp to 5.54%
CYPHERPUNK TECHNOLOGIES INC.−12.16pp to 2.92%
Citi Trends, Inc.−11.67pp to 11.07%
HEALTHCARE REALTY TRUST INC−10.29pp to 6.22%

Changes compare each company's last figure of the quarter with its first; companies with a single report in the quarter are counted but not ranked. Where disclosure thresholds apply the figures are floors, not a census. Nothing here is investment advice.